Genomic, Transcriptomic, and Functional Alterations in DNA Damage Response Pathways as Putative Biomarkers of Chemotherapy Response in Ovarian Cancer

SIMPLE SUMMARY: Several chemotherapy drugs are approved for ovarian cancer treatment in the neo-adjuvant/adjuvant setting as well as following relapse. These include carboplatin, paclitaxel, doxorubicin, topotecan, PARP inhibitors (PARPi), and gemcitabine. However, except for PAPRi, there are no pre...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancers (Basel)
Asıl Yazarlar: Sharma Saha, Sweta, Gentles, Lucy, Bradbury, Alice, Brecht, Dominik, Robinson, Rebecca, O’Donnell, Rachel, Curtin, Nicola J., Drew, Yvette
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8003626/
https://ncbi.nlm.nih.gov/pubmed/33804647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061420
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller